Skip to content

EBITDA margin at other companies

Procter & Gamble logo
Procter & GamblePG
26.8%-0.5pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
34.4%+2.7pp
HRO
HarrowHROW
8%+5.0pp
Cencora logo
CencoraCOR
1.2%0.0pp
Bausch Health Companies logo
Bausch Health CompaniesBHC
17%-11.8pp
Cardinal Health logo
Cardinal HealthCAH
1.3%-0.1pp

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Calculated from Prestige Consumer Healthcare’s reported figures.

Based on trailing twelve months.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's EBITDA margin?
Prestige Consumer Healthcare (PBH) reported EBITDA margin of 31.3% in Q1 2026.
How has Prestige Consumer Healthcare's EBITDA margin changed year-over-year?
Prestige Consumer Healthcare's EBITDA margin decreased by 3.0% year-over-year, from 32.3% to 31.3%.
What is the long-term trend for Prestige Consumer Healthcare's EBITDA margin?
Over 5 years (2021 to 2026), Prestige Consumer Healthcare's EBITDA margin has grown at a -2.1% compound annual growth rate (CAGR), from 34.7% to 31.3%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.